ABOUT IQVIA RESEARCH & DEVELOPMENT SOLUTIONS
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA Research & Development Solutions (RDS) is the full-service clinical development partner that leverages the power of IQVIA Connected Intelligence across your entire study, from study design to site selection, enrollment and execution, so you can deliver life-changing therapies faster and without compromise. Learn more at Research & Development - IQVIA
PARTNER OF CHOICE
-
Designing For Diversity
Embracing diversity enhances our understanding of humanity, fostering empathy and a broader perspective on the world's cultures and behaviors.
-
CRO Industry Trends And Challenges
Kort Schickfus from IQVIA offers insights into the current landscape of R&D trends, outsourcing dynamics, and the essential capabilities required to navigate the intricacies of modern clinical trials.
-
Optimizing Generative AI In Clinical Operations
Crafting a thoughtful strategy to determine the optimal utilization of Generative AI in advancing medical research and enhancing patient well-being.
-
How Clinical Trial Design Impacts Enrollment Of Diverse Populations
Discover the latest findings revealing crucial insights into the factors influencing participants' engagement in clinical trials, offering valuable knowledge about the diverse perspectives and considerations driving participation decisions.
-
Strengthening Pathways For CGTs: Current State And Future Scenarios
This report aims to initiate meaningful discussions about the future role of cell and gene therapies in healthcare and the strategies needed to navigate this dynamic landscape.
-
Global Trends In R&D 2024: Activity, Productivity, And Enablers
This report evaluates trends in new drug launches and the overall number of clinical trials initiated, while also delving into the landscape of R&D funding and the activities of diverse companies.
THERAPEUTICS
-
Optimizing CAGT Post-Trial Long-Term Follow-Up
Uncover how navigating longer study durations presents unique challenges, necessitating efficient data collection methods and flexibility to adapt to evolving patient journeys and regulatory landscapes.
-
Integrating The Younger Patient And Caregiver’s Perspective Into Trial Design
Here, we explore several significant considerations for sponsors seeking to progress drug development while prioritizing the needs and viewpoints of younger patients and their families.
-
Diversity And Inclusion In Oncology Clinical Trials
Despite challenges, learn how sponsors can implement diversity plans to enroll and retain clinically relevant participants, including minorities, older patients, and those with disabilities.
-
The Shifting Paradigm Of Dose Selection In Oncology
Oncology drug development is undergoing a significant transformation. Explore strategies for integrating dose finding and optimization into early clinical development and how it could benefit oncology patients.
-
Pediatric Oncology Trials: Changes On The Horizon
This white paper examines specific considerations and planning for pediatric oncology trials, and the changing landscape in pediatric oncology drug development.
-
Therapeutic Expertise
Connect your clinical program with strong scientific and medical expertise, deep therapeutic insights, and unrivaled clinical trials experience to find the most direct route from breakthrough science to new therapies for patients.
CONTACT INFORMATION
IQVIA Research & Development Solutions
2400 Ellis Road
Durham, NC 27703
UNITED STATES
TRIAL STRATEGY
-
In this sponsored episode of The Top Line, Julia Douthart discusses with Jessica Jones from IQVIA how new technologies streamline clinical trials, easing administrative burdens and enhancing sponsor insights.
-
IQVIA's Director of the Applied Data Science Center Greg Lever discusses patient-centricity and the benefits of flexible trial models driven by smart analytics.
-
Embracing patient centricity isn't just ethically imperative—it's pivotal for fostering greater inclusion among traditionally marginalized groups, fortifying clinical trials, and ultimately, improving healthcare outcomes.
-
Discover how strategies guided by insights will influence the ever-changing clinical trial scene, underscoring the significance of actively engaging patients to enhance the design and execution of trials.
-
Gain insight into the dynamic technological revolution unfolding in respiratory function testing, particularly within wearable connected devices.
-
Jessica Jones, Director of Strategic Technology Delivery and Experience Optimization at IQVIA, discusses the transformative impact of new technologies on clinical trials.
-
In this episode of the Society for Clinical Research Sites Talks podcast, speakers delve into the rising phenomenon of remote clinicians and mobile services within the clinical research domain.
-
The pandemic forced the pharmaceutical industry to reimagine how we recruit patients to clinical trials – and it's delivering significant benefits to sponsors who embrace these changes.
GLOBAL IMPACT
-
A Clearer Harmony And Attractiveness For EU Clinical Trials Regulation
Explore the latest insights on navigating the transition to the EU Clinical Trials Regulation (EU CTR) and ensuring alignment across stakeholders for seamless adaptation in this Pharmaphorum podcast.
-
The Digital Workforce In Clinical Operations
Uncover this general framework for digital transformation — focusing on clinical monitoring processes within the study conduct lifecycle — and how IQVIA AI/ML models harness automation to deliver client value.
-
Meeting Patients Where They Are With Technology
Watch Jeff Spaeder, Chief Medical Officer from IQVIA, discuss how technology helps us meet patients where they are, and is an enabler to making trials more patient centric.
-
The Right Data Management Helps You See The Insights Beyond The Numbers
The IQVIA Clinical Data Repository (CDR) ingests, integrates and standardizes data to drive downstream processes such as real-time data cleaning, decentralized trails, centralized monitoring and machine learning.
-
People Now More Willing Than Ever To Participate In Clinical Trials
A new survey conducted by IQVIA indicates that consumer attention on the development of COVID-19 vaccines and treatments could point to a rising interest in clinical trials participation – and a bonus for future recruiting efforts.
-
Empowering Clinical Trials With Better Devices, Data, And Solutions
In part three of this podcast series, Jeff Noll from IQVIA discusses case studies of solutions customers are asking for right now in the sensors and wearables space and what the future may hold.
-
The Future Of Clinical Monitoring
A fundamental shift in approach is needed to increase efficiency and effectiveness of clinical monitoring, continuing to ensure overall study quality and patient safety while relying more on automation and predictive analytics to continuously evaluate progress, remotely.